mAbDx specializes in creating novel immunodiagnostics through biomarker discovery and immunoassay development. We are committed to developing effective diagnostics for diseases characterized by the common features of great clinical urgency and unmet diagnostic needs.
Latest News
mAbDx and MitoSciences/Abcam sign Master Project Agreement
2012-01-17
mAbDx and MitoSciences/Abcam sign Master Project Agreement for mAbDx to develop medical/clinical diagnostics for: 1) sepsis, 2) SIRS (Systemic Inflammatory Response Syndrome), 3) HNSCC (Head and Neck Squamous Cell Carcinoma), 4) preeclampsia, and 5) inherited Read full article »
mAbDx and University of Oregon Sign Agreement to Support mAbDx monoclonal antibody Development
2011-12-22
mAbDx and the University of Oregon sign a space and care agreement to support mAbDx development of monoclonal antibodies and assays to identify and study mitochondrial DAMPs. Read full article »
mAbDx Moves Laboratory to University of Oregon Innovation Center
2011-11-01
mAbDx moves into new laboratory space in the Innovation Center at the University of Oregon Riverfront Research Park. Read full article »